Our latest news
What We’re Working On
Media Contact
Dan Budwick
dan@1abmedia.com
Bringing Meaningful Therapies from One to Many
-
January 24th, 2024
Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development
Read More -
September 12th, 2023
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
Read More